For vulvar or vaginal cancer, aSHR was 2.40 [1.19–4.84], while aSHRs for anal cancer and oropharyngeal cancer were 1.54 [0.71–3.34] and 1.83 [0.93–3.59], respectively, suggesting increased risks that did not reach statistical significance. 3.4.2.
← all excerpts
Increased Risk of Second Squamous Cell Carcinomas Following Cervical Cancer: A Nationwide Danish Case-Control Study.
1
—
—